Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.58M | -2.47M | -2.47M | -2.35M | -2.46M |
| Total Depreciation and Amortization | 121.70K | 134.90K | 134.90K | 189.10K | 278.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00 | 2.21M | 2.21M | 2.21M | 2.21M |
| Change in Net Operating Assets | -938.50K | -5.44M | -5.44M | -5.04M | -3.95M |
| Cash from Operations | -2.39M | -5.56M | -6.41M | -5.83M | -4.76M |
| Capital Expenditure | -23.20K | -24.10K | -24.10K | -42.30K | -75.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -23.20K | -24.10K | -13.40K | -31.60K | -64.80K |
| Total Debt Issued | 641.70K | 896.60K | 896.60K | 847.20K | 1.08M |
| Total Debt Repaid | -830.90K | -847.70K | -847.70K | -836.50K | 1.10K |
| Issuance of Common Stock | 5.74M | 11.10M | 11.10M | 11.10M | 5.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.60M | -5.56M | -5.56M | -5.58M | -63.90K |
| Cash from Financing | -49.70K | 5.58M | 5.99M | 5.93M | 7.02M |
| Foreign Exchange rate Adjustments | -62.50K | 6.40K | 6.40K | -214.70K | -114.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.53M | -700.00 | 9.50K | 295.90K | 2.52M |